Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?
about
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.Complete remission of VZV reactivation treated with valganciclovir in a patient with total lymphocyte depletion and acute kidney injury after allogeneic bone marrow transplantation.
P2860
Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@ast
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@en
type
label
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@ast
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@en
prefLabel
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@ast
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@en
P2093
P2860
P1476
Can low-dose preemptive valgan ...... eic stem cell transplantation?
@en
P2093
Ahmet Öztürk
Bülent Eser
Ciğdem Pala
Fatih Kurnaz
Gökhan Metan
Haluk Mumcuoğlu
Orhan Yıldız
Selma Gökahmetoğlu
Serdar Şıvgın
P2860
P304
P356
10.1179/1973947813Y.0000000082
P577
2013-10-01T00:00:00Z